Radical perineal prostatectomy without lymphadenectomy in patients with cT1 2, G1 + 2PSA ≤ 10 ng/ml prostate cancer;Die radikale perineale prostatektomie ohne lymphadenektomie. Bei patienten mit cT1 + 2, G1 + 2, PSA ≤ 10 ng/ml prostatakarzinom

Urologe - Ausgabe A

Volumn 38, Issue 2, 1999, Pages 143-149

  Jakse, G ^a   Brehmer, B ^b   Wolff, J M ^b   Aretz, R ^b   Handt, S ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

Lymphadenectomy; Prostate cancer; Prostatectomy; PSA

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MALE; PELVIS LYMPH NODE; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032951684     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050258     Document Type: Article

References (69)

1. Ackermann DA, Barry JM, Wicklund RA, Olson N, Lowe BA (1993) Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol 150: 1845-1850
2. Allepuz Losa CA, Sanz Velez JL, Gil Sanz MJ et al. (1995) Seminal vesicle biopsy in prostate cancer staging. J Urol 154: 1407-1411
3. Babcock JR, Grayhack JT (1979) Mobidity of pelvic lymphadenectomy. Urology 13: 483
4. Bahnson RR, Dresner SM, Gooding W (1989) Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 15: 149-155
5. Bostwick DG (1994) Gleason grading of prostatic needle biopsies: correlation with grade in 316 matched prostatetomies. Am J Surg Pathol 18: 796-803
6. Bostwick DG, Quian J, Bergstralh E, Dundore P, Dugan J, Myers RP, Oesterling JE (1996) Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 155: 1361-1367
7. Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE (1994) Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151: 1315-1320
8. Brendler CB et al (1980) Staging pelvic lymphadenectomy for carcinoma of the prostate: Risk versus benefit. J Urol 124: 849
9. Bruce RG, Rankin WAR, Cibull ML (1996) Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of pathologic stage of disease. Urology 48: 75-79
10. Campbell SC, Klein EA, Levin HS, Piedmonte MR (1995) Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology 46: 352-355
11. Catalona WJ, Stein AJ, Fair WR (1982) Grading errors in prostatic needle biopsies: relation to the accuracy of tumor grade in predicting pelvic lymph node metastases. J Urol 127: 919-922
12. Cookson MS, Fleshner NE, Soloway SM (1997) Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 157: 559-562
13. Cupp MR, Bostwick DG, Myers RP (1995) The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. J Urol 153: 1543-1548
14. Danella JF, DeKernion JB, Smith RB, Steckel J (1993) The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol 149: 1488-1491
15. Dillioglugil Ö, Leibmann BD, Leibmann NS, Kattan MW, Rosas AL, Scardino PT (1997) Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157: 1760-1767
16. Dunzinger M, Sega W, Madersbacher S, Schorn A (1997) Predictive value of the anatomical location of ultrasound-guides systematic sextant prostate biopsies for the nodal status of patients with localized prostate cancer. Eur Urol 31: 317-322
17. Effert P, Boeckmann W, Wolff J, Jakse G (1996) Laparoskopische Lymphadenektomie beim Prostatakarzinom. Urologe [A] 35: 413-417
18. Fah enkamp D, Müller W, Schönberger B, Loening SA (1997) Laparoskopische pelvine Lymphadenektomie (LPLA) in der Diagnostik des lokoregionären Prostatakarzinoms. Akt Ural 28: 35-42
19. Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton jr. CE, Scardino PT (1989) Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142: 332-336
20. Garnet JE, Oyasu R, Grayhack JT (1984) The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J Urol 131: 690-693
21. Goto Y, Ohori M, Arakawa A (1996) Distinguishing clinically important from unimportant prostate cancers before treatment: value of systemic biopsies. J Urol 156: 1059-1063
22. Haggmann M, Nybacka O, Nordin B (1994) Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: localization and prediction of tumour volume and grade. Br J Urol 74: 617-625
23. Hammerer P, Huland H, Sparenberg A (1992) Digital rectal examination, imaging, and systematic-sextant biopsie in identifying operable lymph node-negative prostatic carcinoma. Eur Urol 22: 281-287
24. Henson DE, Hutter RV, Farrow G (1994) Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland: a publication of the Cancer Committee, College of American Pathologists Task Force on the Examination of Specimens Removed from Patients with Prostata Cancer. Arch Pathol Lab Med 118: 779-783
25. Huland H, Ackermann R, Adolfsson J, Arai Y, Andriole GL, Frohmüller H, Gillat D, Ragde H, Rossetti R, Schellhammer PF, Shipley WU (1996) Treatment of localised disease (1996) Treatment of clinically localised prostate cancer (T1/T2). In: Murphy G, Denis L, Chatelain C, Griffiths K, Khoury S, Cockett AT (eds) First international consultation on Prostate Cancer, Monaco - June 20-21-22, pp 227-257
26. Huland H, Hammerer P, Henke RP, Huland E (1996) Preoperative prediction of tumor herogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal examination, prostate specific antigen and the results of 6 systematic biopsies. J Urol 155: 1344-1347
27. Humphrey PA, Baty J, Keetch D (1995) Relationship between serum prostate specific antigen, needle biopsy findings and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer 75: 1842-1849
28. Irwin MB, Trapasso JG (1994) Identification of insignificant prostate cancers: analysis of preoperative parameters. Urology 44: 862-686
29. Kavoussi LR, Sosa E, Chandhoke P, Chodak G, Clayman RV, Hadley HR, Loughlin KR, Ruckle HC, Rukstalis D, Schuessler W, Segura J, Vancaille T, Winfield HN (1993) Complications of laparoscopic pelvic lymph node dissection. J Urol 149: 322
30. Kojima M, Trancoso P, Babaian RJ (1995) Use of prostate-specific antigen and tumour volume in predicting needle biopsy grading error. Urology 45: 807-812
31. Koonce J, Selikowitz S, McDougal WS (1986) Complications of low-dose heparin prophylaxis following pelvic lamphadenectomy. Urology 28: 31
32. Kramer SA, Spahr J, Brendler CB, Glenn JF, Paulson DF (1980) Experience with gleason's histopathologic grading in prostatic cancer. J Urol 124: 223-225
33. Levy DA, Resnick MI (1994) Laparoscopic pelvic lymphadenectomy and radical perineal prostatectomy: a viable alternative to radical retropubic prostatectomy. J Urol 151: 905-908
34. Lieskovsky G, Skinner DG, Weisenburger T (1980) Pelvic lymphadenectomy in the management of carcinoma of the prostate. J Urol 124: 635
35. Linzer DG, Stock RG, Stone NN et al (1996) Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer. Urology 48: 757-761
36. McDowell GC, Johnson JW, Tenney DM, Johnson DE (1990) Pelvic lymphadenectomy for staging clinically localized prostate cancer. Urology 35: 476-482
37. McLaughlin AP, Saltzstein SL, McCullough DL, Gittes RF (1976) Prostatic carcinoma incidence and location of unsuspected lymphatic metastasis. J Urol 115: 89
38. Morgan RW, Lieber MM (1990) Pelvic lymphadenectomy. In: Crawford ED, Sakti DAS (eds) Current genitourinary cancer surgery. Lea & Febiger, Philadelphia-London, chapter 16. pp 162-170
39. Narayan P, Fournier G, Gajendran V, Leidich R, Lo R, Wolf JS, Jacob G, Nicolaisen G, Palmer K, Freiha F (1994) Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 44: 519-524
40. O'Dowd GJ, Veltri RW, Orozco R, Miller C, Oesterling JE (1997) Update on the appropriate staging evaluation for newly diagnosed prostate cancer. J Urol 158: 687-698
41. Oesterling JE, Brendler CB, Epstein JI, Kimball AW, Walsh PC (1987) Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138: 92-98
42. Pandey P, Fowler JE Jr, Seaver LE et al. (1995) Ultrasound guides seminal vesicle biopsies in men with suspected prostate cancer. J Urol 154: 1798-1803
43. Parra RO, Boullier JA, Rauscher JA, Cummings JM (1994) The value of laparoscopic lymphadenectomy in conjunction with radical perineal or retropubic prostatectomy. J Urol 151: 1599-1602
44. Parra RO, Andrus CH, Boullier JA (1992) Staging laparoscopic pelvic lymph node dissection. Arch Surg 127: 1294
45. Partin AW, Kattan MW, Subong ENP, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277: 1445-1451
46. Paul DB, Loening SA, Narayana AS, Culp DA (1983) Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol 129: 1141-1144
47. Paulsen DF (1980) The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. Urol Clin North Am 7: 615-622
48. Peller PA, Young DC, Marmadue DP, Marsh WL, Badalament RA (1995) Sextant prostate biopsies: a histopathologic correlation with radical prostatectomy specimens. Cancer 75: 530-538
49. Pisansky TM, Zincke H, Suman VJ, Bostwick DG, Earle JD, Oesterling JE (1966) Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys 34: 33-39
50. Ravery V, Schmid HP, Toublanc M (1996) Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma? Cancer 78: 1079-1084
51. Ravery V, Boccon-Gibod LA, Dauge-Geffroy MC, Billebaud T, Delmas V, Meulemans A, Torublanc M, Boccon-Gibod L (1994) Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology 44: 372-376
52. Renshaw AA (1997) Adequate tissue sampling of prostate core needle bopsies. Am J Clin Pathol 107: 26-29
53. Rogers E, Gürpinar T, Dillioglugil Ö, Kattan MW, Goads JR, Scardino PT, Griffith DP (1996) The role of digital rectal examinations, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer. Br J Urol 78: 418-425
54. Sadlowski RW, Donahue DJ, Richman AV, Sharpe JR, Finney RP (1983) Accuracy of frozen section diagnosis in pelvic lymph node staging biopsies for adenocarcinoma of the prostate. J Urol 129: 324
55. Sagalowsky AI, Milam H, Reveley LR, Silva FG (1982) Prediction of lymphatic metastases by Gleason histologic grading in prostate cancer. J Urol 128: 951-952
56. Salamao DR, Graham SD, Bostwick DG (1995) Microvascular invasion in prostate cancer correlates with pathologic stage. Arch Pathol Lab Med 199: 1050-1054
57. Sands ME, Zagars GK, Pollack A, Eschenbach AC v (1994) Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer. Urology 44: 215-220
58. Schmid HP, McNeal JE, Freiha FS, Stamey TA (1993) Systematische Methoden zur partiellen Gewebeuntersuchung von radikalen Prostatektomiepräparaten. Der Stellenwert des Tumorvolumens. Akt Urol 24: 33-39
59. Schuessler WW, Vancaillie TG, Reich H, Griffith DP (1991) Transperitoneal endosurgical lymphadenectomy in patients with localized prostate cancer. J Urol 145: 988
60. Shaw EB, Wofford ED, Carter J (1995) Processing prostate needle biopsy specimens for 100% detection of carcinoma. Am J Clin Pathol 15: 604-609
61. Smith jr. JA, Seaman JP, Gleidman JB, Middleton RG (1983) Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients. J Urol 130: 290-292
62. Spires SE, Cibull ML, Wood DP Jr (1994) Gleason histologic grading in prostatic carcinoma: correlation of 18-gauge core biopsy with prostatectomy. Arch Pathol Lab Med 118: 705-708
63. Stamey TA (1995) Making the most out of six systematic sextant biopsies. Urology 45: 2-12
64. Steinberg DM, Sauvageot J, Piantadosi S (1997) Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in adademic and community settings. Am J Surg Pathol 21: 566-576
65. Stone NN, Stock RG, Unger P (1995) Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate. J Urol 154: 1392-1396
66. Thickman D, Speers WC, Philpott PJ, Shapiro H (1996) Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 156: 110-113
67. Weldon VE (1993) Radical perineal prostatectomy. In: Sakti DAS, Crawford ED (eds) Cancer of the prostate. Dekker, Inc, Mew York Basel Hong Kong, pp 225-265
68. Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll PR (1993) Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis. Urology 42: 680-688
69. Zincke H, Farrow GM, Myers RP, Benson RC jr., Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128: 498-501